RTI Biologics names new execs
RTI Biologics has implemented several organizational and leadership changes as part of a companywide initiative to optimize operations, improve cost effectiveness, and provide superior customer service, the company announced. Effective immediately, the following key changes in RTI’s leadership structure have taken place: Robert Jordheim has joined the company as executive vice president and chief financial officer. Thomas F. Rose, executive vice president, has transitioned from the role of chief financial

